全球伴侣动物诊断市场规模、份额、趋势和成长分析报告（2026-2034）

预计到 2034 年，伴侣动物诊断市场规模将从 2025 年的 70.7 亿美元成长至 160.4 亿美元，2026 年至 2034 年的复合年增长率为 9.52%。

随着全球宠物饲养量的增长以及宠物拟人化趋势的日益盛行，伴侣动物诊断市场正蓬勃发展。兽医医院越来越多地使用先进的诊断工具，例如血液分析仪、免疫检测、分子诊断和成像系统，以实现疾病的早期发现并改善治疗效果。预防医学意识的提高也推动了对定期筛检的需求。

宠物医疗保健成本不断上涨、就地检验进步以及快速诊断试剂盒的广泛应用是推动宠物医疗成长要素。携带式分析仪和远距兽医服务的技术创新正在提高宠物医疗服务的可及性和效率。通用感染疾病和宠物慢性病发病率的上升进一步推动了对宠物诊断的需求。

未来前景强劲，主要得益于宠物保险普及率的提高以及新兴市场伴侣动物饲养量的成长。人工智慧辅助诊断平台和基因组检测技术的发展有望改变兽医学。儘管部分地区存在成本方面的担忧，但持续的技术创新以及饲主与其宠物之间深厚的情感纽带预计将支撑市场健康成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球伴侣动物诊断市场：依动物类型划分

• 市场分析、洞察与预测
• 狗
• 猫
• 马
• 其他伴侣动物

第五章：全球伴侣动物诊断市场：依技术划分

• 市场分析、洞察与预测
• 临床生物化学
• 免疫诊断
• 血液学
• 分子诊断
• 尿液检查
• 其他的

第六章 全球伴侣动物诊断市场：依应用领域划分

• 市场分析、洞察与预测
• 临床病理
• 细菌学
• 病毒学
• 寄生虫学
• 其他的

第七章 全球伴侣动物诊断市场：依最终用途划分

• 市场分析、洞察与预测
• 诊断检查室
• 兽医医院和诊所
• 即时检测/院内检测
• 研究机构和大学

第八章：全球伴侣动物诊断市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Zoetis
  • BiomAfA（C）Rieux
  • Heska Corporation
  • Idexx Laboratories Inc
  • Idvet
  • Neogen Corporation
  • Qiagen
  • Randox Laboratories Ltd
  • Thermo Fisher Scientific Inc
  • Virbac

The Companion Animal Diagnostic Market size is expected to reach USD 16.04 Billion in 2034 from USD 7.07 Billion (2025) growing at a CAGR of 9.52% during 2026-2034.

The companion animal diagnostic market has expanded significantly as pet ownership and pet humanization trends rise worldwide. Veterinary clinics increasingly utilize advanced diagnostic tools such as hematology analyzers, immunoassays, molecular diagnostics, and imaging systems to detect diseases early and improve treatment outcomes. Growth in preventive care awareness has also boosted routine screening demand.

Key drivers include higher spending on pet healthcare, advancements in point-of-care testing, and the availability of rapid diagnostic kits. Technological innovation in portable analyzers and tele-veterinary services enhances accessibility and efficiency. Increasing incidence of zoonotic and chronic diseases in pets further fuels diagnostic demand.

Future prospects are strong as pet insurance penetration increases and emerging markets witness rising adoption of companion animals. Development of AI-assisted diagnostic platforms and genomic testing may reshape veterinary care. Despite cost sensitivity in some regions, the market is expected to sustain healthy growth supported by ongoing innovation and emotional attachment between owners and pets.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Animal

• Dogs
• Cats
• Horses
• Other Companion Animals

By Technology

• Clinical Biochemistry
• Immunodiagnostics
• Hematology
• Molecular Diagnostics
• Urinalysis
• Others

By Application

• Clinical Pathology
• Bacteriology
• Virology
• Parasitology
• Others

By End Use

• Diagnostic Laboratories
• Veterinary Hospitals And Clinics
• Point-Of-Care/In-House Testing
• Research Institutes And Universities

COMPANIES PROFILED

• Zoetis, Biomrieux, Heska Corporation, Idexx Laboratories Inc, Idvet, Neogen Corporation, Qiagen, Randox Laboratories Ltd, Thermo Fisher Scientific Inc, Virbac

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL COMPANION ANIMAL DIAGNOSTIC MARKET: BY ANIMAL 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Animal
• 4.2. Dogs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Cats Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Horses Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Other Companion Animals Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL COMPANION ANIMAL DIAGNOSTIC MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Clinical Biochemistry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Immunodiagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Hematology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Molecular Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Urinalysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL COMPANION ANIMAL DIAGNOSTIC MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Clinical Pathology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Bacteriology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Virology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Parasitology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL COMPANION ANIMAL DIAGNOSTIC MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Veterinary Hospitals And Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Point-Of-Care/In-House Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Research Institutes And Universities Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL COMPANION ANIMAL DIAGNOSTIC MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Animal
  • 8.2.2 By Technology
  • 8.2.3 By Application
  • 8.2.4 By End Use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Animal
  • 8.3.2 By Technology
  • 8.3.3 By Application
  • 8.3.4 By End Use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Animal
  • 8.4.2 By Technology
  • 8.4.3 By Application
  • 8.4.4 By End Use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Animal
  • 8.5.2 By Technology
  • 8.5.3 By Application
  • 8.5.4 By End Use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Animal
  • 8.6.2 By Technology
  • 8.6.3 By Application
  • 8.6.4 By End Use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL COMPANION ANIMAL DIAGNOSTIC INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Zoetis
  • 10.2.2 BiomAfA(C)Rieux
  • 10.2.3 Heska Corporation
  • 10.2.4 Idexx Laboratories Inc
  • 10.2.5 Idvet
  • 10.2.6 Neogen Corporation
  • 10.2.7 Qiagen
  • 10.2.8 Randox Laboratories Ltd
  • 10.2.9 Thermo Fisher Scientific Inc
  • 10.2.10 Virbac